Follow $IHI

One email when a member of Congress discloses a trade in it, with the official filing receipt linked.

Free. No account. Unsubscribe in one click.

Follow $IHI by email
ARCX · IHI
-0.52% · -$0.2800 · Vol 1.5M
Market closed · last close 4:00 PM ET · price as of 20:00:00 ET
IHI

iShares U.S. Medical Devices ETF

$53.63
Card
Relationship Map

Veridion Score

Refresh
Score snapshot refresh in progress
Veridion Score History · 90D
Score not reportedVeridion does not publish a score-history trend for IHI until the ticker has a real scored snapshot. No trend is implied for this page.Review methodology
AI Analysis
Sovereign

Why is IHI moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Loading IHI catalysts
About iShares U.S. Medical Devices ETF
Listed since
2006
Country
US
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$53.31
Day high
$53.87
Day low
$53.30
Previous close
$53.91
52W high
$64.47
-16.81% from high
52W low
$47.55
36% of range
Beta
0.03
Shares out
64M
Volume
1.5M
0.61× rel vol
Avg volume
2.5M
VWAP
$53.67
Price history computed in-house
1W
-2.83%
1M
-0.89%
3M
+7.09%
1Y
-14.11%
YTD
-13.71%
SMA 50 $53.07 · above
SMA 200 $55.57 · below
52W position 36%

IHI overview

Financials
Company financial statements are not applicable for IHI.
Loading IHI Form 4 filings
Public disclosures

Congress activity in IHI

Federal contracts

IHI contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for IHI in this window.
Lobbying spend

IHI lobbying filings, year to date.

Registered lobbying filings matched to iShares U.S. Medical Devices ETF.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for IHI in this window.
Loading news for IHI
Analyst ratings
Sovereign unlock shows live analyst consensus for IHI.
Options
Sovereign unlock shows live options positioning for IHI.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.